Dirk W. Kirsten
Net worth: 573 730 $ as of 2026-05-30
Net worth: 573 730 $ as of 2026-05-30
Dirk W.
Kirsten worked as Head-Group Funding & Capital Markets at Roche Holding AG from 2002 to 2004.
From 2004 to 2008, worked as Group Treasurer at Syngenta AG.
From 2008 to 2013, worked as Chief Financial Officer at Nobel Biocare Holding AG.
From 2021 to 2026, worked as Chief Financial Officer at Medartis Holding AG.
Dr. Kirsten earned a doctorate from Universität zu Köln.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MEDARTIS HOLDING AG 0.04% | 2025-12-30 | 5,762 ( 0.04% ) | 573 730 $ | 2026-05-30 |
| Companies | Position | End |
|---|---|---|
| MEDARTIS HOLDING AG | Director of Finance/CFO | 2025-12-31 |
| NOBEL BIOCARE HOLDING AG | Director of Finance/CFO | 2012-12-31 |
| SYNGENTA | Treasurer | 2007-12-31 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 2003-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Syngenta AG
Syngenta AG Information Technology ServicesTechnology Services Develops technologies and farming practices | Technology Services |
Nobel Biocare Holding AG
Nobel Biocare Holding AG Medical SpecialtiesHealth Technology Manfuctures and markets dental equipment, supplies, implants and devices | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medartis Holding AG
Medartis Holding AG Medical SpecialtiesHealth Technology Designs and manufactures orthopedic devices | Health Technology |
Select your edition
All financial news and data tailored to specific country editions